Cargando…

Plasma from patients with pulmonary embolism show aggregates that reduce after anticoagulation

BACKGROUND: Microclots, a term also used for amyloid fibrin(ogen) particles and henceforth named aggregates, have recently been reported in the plasma of patients with COVID-19 and long COVID. These aggregates have been implicated in the thrombotic complications of these diseases. METHODS: Plasma sa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baker, Stephen R., Halliday, Georgia, Ząbczyk, Michal, Alkarithi, Ghadir, Macrae, Fraser L., Undas, Anetta, Hunt, Beverley J., Ariëns, Robert A. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883810/ https://www.ncbi.nlm.nih.gov/pubmed/36709220 http://dx.doi.org/10.1038/s43856-023-00242-8

Ejemplares similares

Recurrent venous thromboembolism patients form clots with lower elastic modulus than those formed by patients with non‐recurrent disease
por: Baker, Stephen R., et al.
Publicado: (2019)

Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice
por: Ząbczyk, Michał, et al.
Publicado: (2023)

Thrombus Structural Composition in Cardiovascular Disease
por: Alkarithi, Ghadir, et al.
Publicado: (2021)

Faster fibrin clot degradation characterizes patients with central pulmonary embolism at a low risk of recurrent peripheral embolism
por: Kupis, Robert W., et al.
Publicado: (2019)

Increased Plasma Clot Permeability and Susceptibility to Lysis Are Associated with Heavy Menstrual Bleeding of Unknown Cause: A Case-Control Study
por: Szczepaniak, Piotr, et al.
Publicado: (2015)

Elevated Lactate Levels in Acute Pulmonary Embolism Are Associated with Prothrombotic Fibrin Clot Properties: Contribution of NETs Formation
por: Ząbczyk, Michał, et al.
Publicado: (2020)

Erythrocyte compression index is impaired in patients with residual vein obstruction
por: Zabczyk, Michal, et al.
Publicado: (2018)

Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism
por: Ząbczyk, Michał, et al.
Publicado: (2021)

Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes
por: Ząbczyk, Michał, et al.
Publicado: (2021)

Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease
por: Undas, Anetta
Publicado: (2023)

Adverse outcomes in anticoagulated patients undergoing percutaneous left atrial appendage ligation
por: Undas, Anetta
Publicado: (2020)

Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes
por: Kopytek, Magdalena, et al.
Publicado: (2020)

Diabetes concomitant to aortic stenosis is associated with increased expression of NF-κB and more pronounced valve calcification
por: Kopytek, Magdalena, et al.
Publicado: (2021)

Towards Personalized Therapy of Aortic Stenosis
por: Mazur, Piotr, et al.
Publicado: (2021)

PAI-1 Overexpression in Valvular Interstitial Cells Contributes to Hypofibrinolysis in Aortic Stenosis
por: Kopytek, Magdalena, et al.
Publicado: (2023)

Architecture of fibrin network inside thrombotic material obtained from the right atrium and pulmonary arteries: flow and location matter
por: Mazur, Piotr, et al.
Publicado: (2012)

Practical considerations on non-vitamin K oral anticoagulants in patients with high body weight
por: Undas, Anetta
Publicado: (2016)

Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence
por: Undas, Anetta
Publicado: (2017)

Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk
por: Ząbczyk, Michał, et al.
Publicado: (2020)

Differences in plasma fibrin clot composition in patients with thrombotic antiphospholipid syndrome compared with venous thromboembolism
por: Stachowicz, Aneta, et al.
Publicado: (2018)

How to Optimize the Administration of Low-Dose Non-vitamin K Antagonist Oral Anticoagulants in Everyday Practice?
por: Undas, Anetta
Publicado: (2022)

Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation
por: Zalewski, Jarosław, et al.
Publicado: (2016)

Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
por: Undas, Anetta, et al.
Publicado: (2020)

Decreased Levels of Histidine-Rich Glycoprotein in Advanced Lung Cancer: Association with Prothrombotic Alterations
por: Winiarska, Aleksandra, et al.
Publicado: (2019)

P1643: FIBRIN CLOT PROPERTIES IDENTIFY PATIENTS THAT BENEFIT FROM CATHETER-DIRECTED THROMBOLYSIS: A POST HOC ANALYSIS OF THE CAVA TRIAL
por: Iding, Aaron F.J., et al.
Publicado: (2023)

Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease: Practical Issues
por: Matusik, Paweł T., et al.
Publicado: (2022)

Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype
por: Natorska, Joanna, et al.
Publicado: (2023)

Unexplained thrombosis of the aortic arch with distal embolization in a patient with altered fibrin clot properties
por: Ciurus, Tomasz, et al.
Publicado: (2012)

Impaired fibrinolysis and lower levels of plasma α(2)-macroglobulin are associated with an increased risk of severe asthma exacerbations
por: Bazan-Socha, Stanislawa, et al.
Publicado: (2017)

Fibrin structure in organized thrombotic material removed during pulmonary artery endarterectormy: the effect of vessel calibre
por: Mazur, Piotr, et al.
Publicado: (2016)

Anticoagulants and the Propagation Phase of Thrombin Generation
por: Orfeo, Thomas, et al.
Publicado: (2011)

Association of NT-proBNP and GDF-15 with markers of a prothrombotic state in patients with atrial fibrillation off anticoagulation
por: Matusik, Paweł T., et al.
Publicado: (2019)

Polyhedrocytes in blood clots of type 2 diabetic patients with high cardiovascular risk: association with glycemia, oxidative stress and platelet activation
por: Gajos, Grzegorz, et al.
Publicado: (2018)

Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception
por: Piróg, Magdalena, et al.
Publicado: (2019)

Altered platelet reactivity, coagulation, endothelial and inflammatory markers early after smoking cessation verified with cotinine plasma concentration
por: Ramotowski, Bogumił, et al.
Publicado: (2023)

Prothrombotic State in Asthma Is Related to Increased Levels of Inflammatory Cytokines, IL-6 and TNFα, in Peripheral Blood
por: Bazan-Socha, Stanislawa, et al.
Publicado: (2017)

P1699: ANTITHROMBIN DEFICIENCY IS ASSOCIATED WITH PROTHROMBOTIC FIBRIN CLOT PHENOTYPE
por: Zabczyk, M., et al.
Publicado: (2022)

How to improve the management of a patient with heparin-induced thrombocytopenia?
por: Undas, Anetta
Publicado: (2019)

Plasma Fibrin Clot Properties as Determinants of Bleeding Time in Human Subjects: Association with Histidine-Rich Glycoprotein
por: Szułdrzyński, Konstanty, et al.
Publicado: (2020)

Neutrophil-activating Peptide 2 as a Novel Modulator of Fibrin Clot Properties in Patients with Atrial Fibrillation
por: Ząbczyk, Michał, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ft2dagos1d0pio7354sf1bikhn